Interestingly, LRRK2 expression was upregulated in B cells, T cells and CD16 monocytes from sporadic PD patients compared to healthy controls [152], highlighting cell type specificity as an important factor in biomarker studies. This evidence concerns the gene LRRK2 and Parkinson disease.